immune system
• treatment of FLT3-cDCs with polyinosinic:polycytidylic acid [poly(I:C)], does not increase the number of galectin 3+ phagosomes as is seen in wild-type FLT3L-cDCs indicating that phagosomal rupture is impaired
• however, mice exhibit normal myeloid and lymphoid composition, including similar amounts of type 1 conventional dendritic cells (cDC1s) and type 2 conventional dendritic cells (cDC2s)
|
• FLT3L-cDCs have a defect in ability to cross-present OVA-beads to both B3Z cells and to OT-I cells
• FLT3L-cDC1s have a large defect in their ability to cross-present OVA-beads
• FLT3L-cDC2s have a modest defect in their ability to cross-present OVA-beads
• however, neither FLT3L-cDC1s nor FLT3L-cDC2s have any defect in their ability to directly present OVA SIINFEKL peptide
• mice immunized with OVA-beads + poly(I:C) show a reduced OVA-specific CD8+ T cell response
• mice immunized with ultraviolet-irradiated, OVA-coated NIH-3T3 cells (H-2q) + poly(I:C) show a reduced OVA-specific CD8+ T cell response indicating an inability to cross-present dead cell-associated antigens
|